cancer drug

1 stories · following the connections

Business

PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY

By Nasdaq OMXApr 18, 2018, 10:00 AM UTC